Recent News

• 02.12.2026 - SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
• 01.09.2026 - 8-K - Current report
• 01.05.2026 - 4 - Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 - Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 - Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 - Statement of changes in beneficial ownership of securities
• 12.11.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 12.11.2025 - 8-K - Current report
• 12.11.2025 - Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
• 11.19.2025 - Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform

Recent Filings

• 01.09.2026 - 8-K Current report
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.11.2025 - EX-99.1 EX-99.1
• 12.11.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 12.11.2025 - 8-K Current report